These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3215483)

  • 1. Studies of the in vitro human plasma degradation of methionine-enkephalin.
    Mosnaim AD; Puente J; Wolf ME; Callaghan OH; Busch R; Diamond S
    Gen Pharmacol; 1988; 19(5):729-33. PubMed ID: 3215483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation kinetics of leucine5-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects.
    Mosnaim AD; Wolf ME; Nguyen TD; Puente J; Freitag F; Diamond S
    Am J Ther; 2000 May; 7(3):185-94. PubMed ID: 11317167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
    Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
    J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
    Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-ECD determination of the enzymatic hydrolysis of [leu]- and [met]enkephalin in rat plasma.
    Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
    Prog Clin Biol Res; 1990; 328():253-6. PubMed ID: 1968263
    [No Abstract]   [Full Text] [Related]  

  • 11. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
    Aoki K; Kajiwara M; Oka T
    Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
    Agu RU; Vu Dang H; Jorissen M; Kinget R; Verbeke N
    Peptides; 2004 Apr; 25(4):563-9. PubMed ID: 15165710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro methionine5-enkephalin degradation kinetics by human brain preparations.
    Mosnaim AD; Nguyen TD; Tse R; Puente J; Couceyro P; Wolf ME
    Neurochem Res; 2008 Jan; 33(1):81-6. PubMed ID: 17676390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML; Geary LE; Wiley KS
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new aminopeptidase in monkey cerebral membrane fraction: hydrolysis of enkephalin.
    Shimamura M; Hazato T; Iwaguchi T
    Brain Res; 1988 Apr; 445(2):350-3. PubMed ID: 3370467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics of methionine5-enkephalin by select brain areas from patients with chronic schizophrenia.
    Mosnaim AD; Nguyen TD; Puente J; Wolf ME
    Am J Ther; 2008; 15(2):126-30. PubMed ID: 18356632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.
    Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):373-7. PubMed ID: 7616421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum.
    van Amsterdam JG; van Buuren KJ; Krielaart MJ; Zuiderveld OP; Tijms RP
    Life Sci; 1988; 43(19):1529-36. PubMed ID: 3193845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid.
    Benter IF; Hirsh EM; Tuchman AJ; Ward PE
    Biochem Pharmacol; 1990 Aug; 40(3):465-72. PubMed ID: 1974424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.